Skip to Main Content

Clinical guidelines

Read the following Clinical Guidelines, published in European Journal of Endocrinology and freely available:

Prevention and treatment of glucocorticoid-induced osteoporosis in adults: recommendations from the European Calcified Tissue Society
Julien Paccou and others
European Journal of Endocrinology, Volume 191, Issue 6, December 2024, Pages G1–G17, https://doi.org/10.1093/ejendo/lvae146
Introduction This report presents the recommendations of the European Calcified Tissue Society (ECTS) for the prevention and treatment of glucocorticoid-induced osteoporosis (GIOP) in adults. Our starting point was that the recommendations be evidence based, focused on non-bone specialists who ...
Clinical practice guidelines for the care of girls and women with Turner syndrome: Proceedings from the 2023 Aarhus International Turner Syndrome Meeting
Claus H Gravholt and others
European Journal of Endocrinology, Volume 190, Issue 6, June 2024, Pages G53–G151, https://doi.org/10.1093/ejendo/lvae050
Turner syndrome (TS) affects 50 per 100 000 females. TS affects multiple organs through all stages of life, necessitating multidisciplinary care. This guideline extends previous ones and includes important new advances, within diagnostics and genetics, estrogen treatment, fertility, co-morbidities, ...
European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and therapy of glucocorticoid-induced adrenal insufficiency
Felix Beuschlein and others
European Journal of Endocrinology, Volume 190, Issue 5, May 2024, Pages G25–G51, https://doi.org/10.1093/ejendo/lvae029
Glucocorticoids are widely prescribed as anti-inflammatory and immunosuppressive agents. This results in at least 1% of the population using chronic glucocorticoid therapy, being at risk for glucocorticoid-induced adrenal insufficiency. This risk is dependent on the dose, duration and potency of ...
Familial hyperaldosteronism: an European Reference Network on Rare Endocrine Conditions clinical practice guideline
Paolo Mulatero and others
European Journal of Endocrinology, Volume 190, Issue 4, April 2024, Pages G1–G14, https://doi.org/10.1093/ejendo/lvae041
We describe herein the European Reference Network on Rare Endocrine Conditions clinical practice guideline on diagnosis and management of familial forms of hyperaldosteronism. The guideline panel consisted of 10 experts in primary aldosteronism, endocrine hypertension, paediatric endocrinology, and ...
International consensus on mitotane treatment in pediatric patients with adrenal cortical tumors: indications, therapy, and management of adverse effects
Maria Riedmeier and others
European Journal of Endocrinology, Volume 190, Issue 4, April 2024, Pages G15–G24, https://doi.org/10.1093/ejendo/lvae038
Objective Mitotane is an important cornerstone in the treatment of pediatric adrenal cortical tumors (pACC), but experience with the drug in the pediatric age group is still limited and current practice is not guided by robust evidence. Therefore, we have compiled international consensus statements ...
Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome
Helena J Teede and others
European Journal of Endocrinology, Volume 189, Issue 2, August 2023, Pages G43–G64, https://doi.org/10.1093/ejendo/lvad096
Study question What is the recommended assessment and management of those with polycystic ovary syndrome (PCOS), based on the best available evidence, clinical expertise, and consumer preference? Summary answer International evidence-based guidelines address prioritized questions and outcomes and ...
European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors
Martin Fassnacht and others
European Journal of Endocrinology, Volume 189, Issue 1, July 2023, Pages G1–G42, https://doi.org/10.1093/ejendo/lvad066
Adrenal incidentalomas are adrenal masses detected on imaging performed for reasons other than suspected adrenal disease. In most cases, adrenal incidentalomas are nonfunctioning adrenocortical adenomas but may also require therapeutic intervention including that for adrenocortical carcinoma, ...
Endocrine-related adverse conditions in patients receiving immune checkpoint inhibition: an ESE clinical practice guideline
Eystein S Husebye and others
European Journal of Endocrinology, Volume 187, Issue 6, 1 December 2022, Pages G1–G21, https://doi.org/10.1530/EJE-22-0689
Immune checkpoint inhibitors (ICI) have revolutionized cancer treatment but are associated with significant autoimmune endocrinopathies that pose both diagnostic and treatment challenges. The aim of this guideline is to provide clinicians with the best possible evidence-based recommendations for ...
Pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency: an Endo-ERN clinical practice guideline
A Nordenström and others
European Journal of Endocrinology, Volume 186, Issue 6, Jun 2022, Pages G9–G49, https://doi.org/10.1530/EJE-22-0073
An Endo-European Reference Network guideline initiative was launched including 16 clinicians experienced in endocrinology, pediatric and adult and 2 patient representatives. The guideline was endorsed by the European Society for Pediatric Endocrinology, the European Society for Endocrinology and ...
The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy
L Bartalena and others
European Journal of Endocrinology, Volume 185, Issue 4, Oct 2021, Pages G43–G67, https://doi.org/10.1530/EJE-21-0479
Graves’ orbitopathy (GO) is the main extrathyroidal manifestation of Graves’ disease (GD). Choice of treatment should be based on the assessment of clinical activity and severity of GO. Early referral to specialized centers is fundamental for most patients with GO. Risk factors include smoking, ...
ESE Clinical Practice Guideline on functioning and nonfunctioning pituitary adenomas in pregnancy
A Luger and others
European Journal of Endocrinology, Volume 185, Issue 3, Sep 2021, Pages G1–G33, https://doi.org/10.1530/EJE-21-0462
Pregnancies are rare in women with pituitary adenomas, which may relate to hormone excess from secretory subtypes such as prolactinomas or corticotroph adenomas. Decreased fertility may also result from pituitary hormone deficiencies due to compression of the gland by large tumours and/or surgical ...
European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity
R Pasquali and others
European Journal of Endocrinology, Volume 182, Issue 1, Jan 2020, Pages G1–G32, https://doi.org/10.1530/EJE-19-0893
Obesity is an emerging condition, with a prevalence of ~20%. Although the simple measurement of BMI is likely a simplistic approach to obesity, BMI is easily calculated, and there are currently no data showing that more sophisticated methods are more useful to guide the endocrine work-up in ...
European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors
Martin Fassnacht and others
European Journal of Endocrinology, Volume 179, Issue 4, Oct 2018, Pages G1–G46, https://doi.org/10.1530/EJE-18-0608
Adrenocortical carcinoma (ACC) is a rare and in most cases steroid hormone-producing tumor with variable prognosis. The purpose of these guidelines is to provide clinicians with best possible evidence-based recommendations for clinical management of patients with ACC based on the GRADE (Grading of ...
European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas
Gerald Raverot and others
European Journal of Endocrinology, Volume 178, Issue 1, Jan 2018, Pages G1–G24, https://doi.org/10.1530/EJE-17-0796
Background Pituitary tumours are common and easily treated by surgery or medical treatment in most cases. However, a small subset of pituitary tumours does not respond to standard medical treatment and presents with multiple local recurrences (aggressive pituitary tumours) and in rare occasion with ...
Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting
Claus H Gravholt and others
European Journal of Endocrinology, Volume 177, Issue 3, Sep 2017, Pages G1–G70, https://doi.org/10.1530/EJE-17-0430
Turner syndrome affects 25–50 per 100,000 females and can involve multiple organs through all stages of life, necessitating multidisciplinary approach to care. Previous guidelines have highlighted this, but numerous important advances have been noted recently. These advances cover all specialty ...
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
Martin Fassnacht and others
European Journal of Endocrinology, Volume 175, Issue 2, Aug 2016, Pages G1–G34, https://doi.org/10.1530/EJE-16-0467
By definition, an adrenal incidentaloma is an asymptomatic adrenal mass detected on imaging not performed for suspected adrenal disease. In most cases, adrenal incidentalomas are nonfunctioning adrenocortical adenomas, but may also represent conditions requiring therapeutic intervention (e.g. ...
European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma
P F Plouin and others
European Journal of Endocrinology, Volume 174, Issue 5, May 2016, Pages G1–G10, https://doi.org/10.1530/EJE-16-0033
Phaeochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumours. Standard treatment is surgical resection. Following complete resection of the primary tumour, patients with PPGL are at risk of developing new tumoural events. The present guideline aims to propose standardised clinical ...
European Society of Endocrinology Clinical Guideline: Treatment of chronic hypoparathyroidism in adults
Jens Bollerslev and others
European Journal of Endocrinology, Volume 173, Issue 2, Aug 2015, Pages G1–G20, https://doi.org/10.1530/EJE-15-0628
Hypoparathyroidism (HypoPT) is a rare (orphan) endocrine disease with low calcium and inappropriately low (insufficient) circulating parathyroid hormone levels, most often in adults secondary to thyroid surgery. Standard treatment is activated vitamin D analogues and calcium supplementation and not ...
Clinical practice guideline on diagnosis and treatment of hyponatraemiaThe guidelines were peer reviewed by the owner societies and by external referees prior to publication.
Goce Spasovski and others
European Journal of Endocrinology, Volume 170, Issue 3, Mar 2014, Pages G1–G47, https://doi.org/10.1530/EJE-13-1020
Hyponatraemia, defined as a serum sodium concentration <135 mmol/l, is the most common disorder of body fluid and electrolyte balance encountered in clinical practice. It can lead to a wide spectrum of clinical symptoms, from subtle to severe or even life threatening, and is associated with ...
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close